Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aytu BioPharma
AddedFeb 19, 2024
UpdatedJul 5, 2026
Aytu BioPharma

Aytu BioPharma

Public

Aytu BioPharma: A global specialty healthcare firm focusing on urological disorders and male infertility.

HQ
Englewood, CO, US
Founded
2015
Overview
Compare
Fundraising
Employees
Website

Founded with a mission to improve patient health globally, Aytu BioPharma, Inc. is a specialty healthcare company that focuses on acquiring, developing, and commercializing innovative products for complex conditions. The company's core areas of expertise include sexual dysfunction disorders, urological cancer, urinary tract infections, male infertility, and ADHD. Aytu BioPharma aims to enhance patient wellness through a diverse portfolio of prescription therapeutics designed to help patients lead healthier and more fulfilling lives.

Aytu BioPharma has garnered attention for its impactful contributions to healthcare, supported by a team of dedicated professionals and strategic investors. The company has achieved significant milestones in advancing treatments for ADHD and urological disorders, reflecting its commitment to addressing unmet medical needs. Through its innovative therapies and global reach, Aytu BioPharma continues to make a substantial impact on patient care and the broader healthcare landscape.

Aytu BioPharma - Similar Companies

Aptinyx logo

Aptinyx

aptinyx.com

UroGen Pharma logo

UroGen Pharma

urogen.com

Harmony Biosciences logo

Harmony Biosciences

Arbutus Biopharma logo

Arbutus Biopharma

arbutusbio.com

Auxilius Pharma logo

Auxilius Pharma

auxiliuspharma.com

PTC Therapeutics logo

PTC Therapeutics

ptcbio.com

Aya Biosciences logo

Aya Biosciences

bioaya.com

Superior Biologics logo

Superior Biologics

Attune Pharmaceuticals logo

Attune Pharmaceuticals

Assertio Holdings logo

Assertio Holdings

Astria Therapeutics logo

Astria Therapeutics

astriatx.com

aTyr Pharma logo

aTyr Pharma

atyrpharma.com

Lumos Pharma logo

Lumos Pharma

lumos-pharma.com

Granata Bio logo

Granata Bio

granata.bio

Accuitis logo

Accuitis

accuitis.com

Aytu BioPharma - Quick Facts

Who are Aytu BioPharma's competitors?

Companies similar to Aytu BioPharma include Aptinyx, UroGen Pharma, Harmony Biosciences and Arbutus Biopharma.

When was Aytu BioPharma founded?

Aytu BioPharma was founded in 2015.

Where is Aytu BioPharma's headquarters located?

Aytu BioPharma's headquarters is located in Englewood, CO, US.

When was Aytu BioPharma's last funding round?

Aytu BioPharma's most recent funding round was for $4M (USD) in June 2023.

How much has Aytu BioPharma raised to-date?

As of Jun 9, 2023, Aytu BioPharma has raised a total of $36M (USD).

How many employees does Aytu BioPharma have?

Aytu BioPharma has 164 employees as of Feb 6, 2024.

Aytu BioPharma - Classification

Ownership
  • Public
Technology
  • Biotech
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Consumers
  • Enterprise
Main Product
  • Pharmaceuticals
  • Therapeutics
Tags
  • Healthtech
  • Pharmaceuticals
Unique IDs
  • secCik: 0001385818
  • ticker: AYTU
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 2800Chemicals And Allied Products
  • 2830Drugs
  • 2834Pharmaceutical Preparations
ISIC
  • 2100Manufacture of pharmaceuticals, medicinal chemical and botanical products
Show 25 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 424000Merchant Wholesalers, Nondurable Goods
  • 424200Drugs and Druggists' Sundries Merchant Wholesalers
  • 424210Drugs and Druggists' Sundries Merchant Wholesalers
  • 420000Wholesale Trade
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 623000Nursing and Residential Care Facilities
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 5100Wholesale trade--nondurable goods
  • 5120Drugs, Drug Proprietaries, And Druggists' Sundries
  • 5122Drugs, Drug Proprietaries, and Druggists' Sundries
  • 8733Noncommercial Research Organizations
  • 4000Railroad Transportation
  • 6000Depository Institutions
  • 8000Health Services
  • 8200Educational Services
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8730Research, Development, And Testing Services
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified
  • 8731Commercial Physical and Biological Research
ISIC
  • 4649Wholesale of other household goods